ArticleJournal of gastroenterology and hepatology2025

Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern.

Paulina Suo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.